DeepMind and major funders accelerate AI-biology infrastructure

DeepMind's AlphaGenome claims million-base genomic modeling, base-pair resolution, open weights, and top performance on 25 of 26 benchmarks, with biological validation still pending. Meta- and Google-linked groups committed $300 million to Biohub's broader $1.8 billion program; gene-generation and de-extinction claims remain pre-validation, unlike experimentally validated ML-designed OLED materials.